跳至主要内容
临床试验/JPRN-UMIN000008959
JPRN-UMIN000008959已完成1 期

Trial of molecular hydrogen water in Multiple system atrophy and Progressive supranuclear palsy - Randomized Double-blind, Placebo-controlled trial on molecular hydrogen water in MSA and PSP

Juntendo University School of Medicine, Department of Neurology0 个研究点目标入组 40 人开始时间: 2012年10月16日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) The patient with corticobasal degeneration, and other disease with parkisonism. 2) Dysphagia for liquid. Part I-2 of unified MSA rateing scale (UMSARS) is over 2, 13th of Japanese PSP rating scale (PSPRS-J) is over 2. 3) The presence of other serious disease. 4) The presence of malignant tumor. 5) The presence of adverce event caused with dopaminagonist. 6) Subjects which are inappropriate for the study according to our judgment.

研究者

发起方
Juntendo University School of Medicine, Department of Neurology

相似试验

Trial of molecular hydrogen water in Multiple system... | 临床试验